Ajanta Pharma Ltd - Quarterly Results - Q1 FY 2013-14 (June 2013) - NET SALES UP 45% ; NPT UP 38%YoY

Ajanta Pharma Limited

Quarterly Results

Q1 FY 2013-14 (June 2013)

Ajanta Pharma has reported good results for the first quarter ending June 2013.

Net Sales for Q1 FY 14 stands at Rs.215.39 Cr, down by -13.57% sequentially (Q4 FY 13:Rs.249.21 Cr); and up by a good 45.07% compared to the corresponding Quarter of FY 13 (Q1 FY13 : Rs.171.79 Cr).

Total Expenditure  for Q1 FY 14 stands at Rs.176.45    Cr, down by -7.13% sequentially (Q4 FY 13:Rs.189.99 Cr); and up by 31.26% compared to the corresponding Quarter of FY 13 (Q1 FY13 : Rs.144.74 Cr).

Profit before Interest, Dep. & Taxes   for Q1 FY 14 stands at Rs.38.94 Cr, down by -34.25 % sequentially (Q4 FY 13:Rs.59.22Cr); and up by 118.93% compared to the corresponding Quarter of FY 13 (Q1 FY13 : Rs.27.05 Cr).

Profit before tax    for Q1 FY 14 stands at Rs.47.72      Cr, down by -20.97       % sequentially (Q4 FY 13:Rs.60.38 Cr); and up by 161.16% compared to the corresponding Quarter of FY 13 (Q1 FY13 : Rs.23.12Cr).

Tax Expenses for Q1 FY 14 stands at Rs.15.18 Cr, down by -54.4 % sequentially (Q4 FY 13:Rs.33.29 Cr); and up by 840.4% compared to the corresponding Quarter of FY 13 (Q1 FY13 : Rs.3.54Cr). Tax expenses are thus down sequentially, but are a Huge up compared to Q1 FY 13.

Net Profit  for Q1 FY 14 stands at Rs.32.54      Cr, up by 20.12% sequentially (Q4 FY 13:Rs.27.09 Cr); and up by 38.36% compared to the corresponding Quarter of FY 13 (Q1 FY13 : Rs.19.58 Cr).

Diluted EPS on a Face Value of Rs.5 - for Q1 FY 14 stands at Rs.13.86  ; compared to Rs.11.53 in Q4 FY 13; and Rs.  16.68 in Q1 FY 13.

RESULTS TABLE

AJANTA PHARMA	30-06-13	%QoQ DIF	31-03-13	31-12-12	30-09-12	%YoY DIF	30-06-12
Net Sales	21539	-13.57	24921	22568	18368	45.07	17179
Total Expenditure	17645	-7.13	18999	17756	15106	31.26	14474
Profit before Interest, Dep. & Taxes	3894	-34.25	5922	4812	3262	118.93	2705
Net Profit	3254	20.12	2709	3257	2188	38.36	1958
Diluted EPS	13.86	20.21	11.53	13.88	9.32	-30.88	16.68
Total Income	21894	-12.23	24944	22934	18637	43.32	17405
Changes in inventories	1614	-192.44	-1746	-271	-672	-212.79	1548
Cost of materials	5083	-48.84	9936	7995	6040	123.88	4438
Purchases of stock-in-trade	759	1.74	746	800	661	41.29	528
Employee benefits	3385	-1.94	3452	2777	2748	34.69	2563
Depreciation	860	-4.23	898	806	788	15.42	778
Other expenses	5944	4.04	5713	5649	5541	23.68	4619
Total expenses	17645	-7.13	18999	17756	15106	31.26	14474
Profit before tax	4772	-20.97	6038	4888	3113	161.16	2312
Tax Expenses	1518	-54.4	3329	1631	925	840.4	354
Net Profit	3254	20.12	2709	3257	2188	38.36	1958
Face Value of Share (in )	5	0	5	5	5	-50	10
Paid-up Equity	1181	0.08	1180	1180	1180	0	1180
Basic EPS	13.89	20.16	11.56	13.91	9.34	-30.86	16.72
Diluted EPS	13.86	20.21	11.53	13.88	9.32	-30.88	16.68
Public holding (%)	26.54	-1.7	27	27.3	27.3	-4.12	28.16

 *  *  *  E  N  D  *  *  *